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A B S T R A C T   
In vertebrates, the somatotropic axis comprising the pituitary gland, liver and muscle plays a major role in 
myogenesis. Its output in terms of muscle growth is highly affected by nutritional and environmental cues, and 
thus likely epigenetically regulated. Hydroxymethylation is emerging as a DNA modification that modulates gene 
expression but a holistic characterization of the hydroxymethylome of the somatotropic axis has not been 
investigated to date. Using reduced representation 5-hydroxymethylcytosine profiling we demonstrate tissue- 
specific localization of 5-hydroxymethylcytosines at single nucleotide resolution. Their abundance within gene 
bodies and promoters of several growth-related genes supports their pertinent role in gene regulation. We 
propose that cytosine hydroxymethylation may contribute to the phenotypic plasticity of growth through 
epigenetic regulation of the somatotropic axis.   
1. Introduction 
Somatic growth requires a well-tuned transcriptional synchroniza-
tion of three main tissue types that compose the somatotropic axis: the 
pituitary gland, liver and skeletal muscle. From the production of 
growth hormone (GH) in the pituitary gland to the stimulation and 
regulation of hundreds of genes in the liver and muscle, the somato-
tropic axis plays a critical role across several biological pathways 
involved in somatic growth, carbohydrate and lipid metabolism, energy 
equilibrium, normal development and reproduction [1–3]. The insulin- 
like growth factors (IGF-I and -II), their receptors (IGFRS) and binding 
proteins (IGFBPS) that are present in substantial amounts in liver and 
fast muscle, are directly associated with GH and collectively regulate 
somatic growth. However, the interaction of these molecules is greatly 
affected by both endogenous and exogenous factors, i.e. sex, develop-
mental stage, nutrition, genetic background, temperature, photoperiod, 
salinity, dissolved oxygen, immunocompetence and stress [4–7]. For 
example, previous research has shown that seasonal differences [8], 
photoperiod, and sexual maturity [9] affect insulin-like growth factor 1 
(igf1) plasma levels and consequently somatic growth. In addition, the 
liver is the main source of igf1 production; however, in cases of 
malnutrition the liver is predominantly unresponsive to GH stimulation 
[10]. Such interactions have been widely demonstrated and both 
endocrine and paracrine igf1 have been linked to bone, cartilage and 
muscle growth across vertebrates [11]. 
Because growth rate varies considerably with environmental factors 
[12], epigenetic mechanisms, which are known to integrate genomic 
and environmental information to bring about the phenotype [13], have 
the potential to be major regulators of growth both in early development 
(e.g., thermal imprinting) [14–16], and adulthood. Indeed, intrauterine 
growth restriction in rats induces DNA methylation changes around 
growth hormone response elements of the IGF-1 gene, resulting in 
developmental re-programming and persisting long-term effects [17]. 
Additionally, epigenetic mechanisms are likely responsible for splicing 
events leading to the translation of tissue-specific IGF-1 peptides 
through the usage of alternative promoters and exons [18,19]. In 
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teleosts, recent studies have shown that epigenetic modifications regu-
late the expression of important growth genes during temperature 
fluctuations such as the DNA methylation of myogenin in Atlantic salmon 
(Salmo salar) [20] and Senegalese sole (Solea senegalensis) [14,21]. We 
have recently reported that growth-related methylation differences in 
igf2bp2 are likely linked to phenotypic differences between small and 
large Nile tilapia full-sibs [22]. We identified sex-specific DNA methyl-
ation marks within the map3k5, akt3, gadd45g and ppargc1a genes. Their 
epigenetic regulation could potentially explain size-related differences 
among sexes because of their involvement in processes such as cell cycle, 
proliferation, cellular response to glucose and muscle tissue develop-
ment [22]. The epigenetic function of non-coding RNAs, such as 
microRNAs (miRNAs), has also been shown to play critical roles in so-
matic growth [15]. For example, miR-206 targets the 3’UTR of IGF-1 
and directly affects its expression in Nile tilapia [23], while miR-1 and 
miR-133 regulate the sarcomeric actin organization in zebrafish [24]. 
Similar results have been shown in mammalian cells, such as hepato-
cellular carcinoma cells, where miR-190b directly regulates IGF-I 
expression [25]. DNA methylation plays also an important role within 
the GH/IGF-I axis. Recent studies have identified the P2 promoter of 
IGF-I to be epigenetically mediated by DNA methylation with significant 
consequences in IGF-I circulation and human growth [26,27]. Although 
DNA methylation is an epigenetic modification that has received much 
attention in response to several biological contexts, including the func-
tion and regulation of major components of the somatotropic axis, little 
is known for its oxidized derivative. DNA hydroxymethylation is an 
epigenetic modification that occurs via ten-eleven-translocation en-
zymes, which catalyse the oxidation of 5-methyl (-CH3) into 5-hydroxy-
methyl (-CH2OH) groups in cytosines (5hmCs) [28]. Additionally, 5hmC 
has been identified as a stable DNA modification with a pertinent role in 
gene regulation and transcription [29,30], tissue-specific patterns and 
developmental stage-dependent profiles [31]. In human, 5hmCs are not 
exclusively correlated with DNA methylcytosine (5mC) content and 
when found in transcribed gene bodies they have been positively 
correlated with transcription [32]. In spite of 5hmC’s significance in 
regulating gene expression in humans [31–33] and mice [34,35], little is 
known about its role on growth, especially taking into account that it has 
been associated with abnormal growth, cancers and oncogenic pathways 
such as the PI3K-Akt [36,37]. 
Growth hormone signaling and the overall function of the somato-
tropic axis is largely conserved through evolution between fishes and 
higher vertebrates [38]. In contrast to mammals, most teleosts are 
poikilothermic and thus their growth rate is influenced to a greater 
extent by variations in environmental factors such as temperature. 
Furthermore, mammals have a determinate growth in comparison to 
many teleost species, which exhibit indeterminate growth. Together, the 
functional conservation of the somatotropic axis and the peculiarities 
described above, make teleosts excellent models for the investigation of 
epigenetic mechanisms that modulate the somatotropic axis. In this 
study, we compared genome-wide and tissue-specific 5hmC profiles at 
single nucleotide resolution between pituitary, liver and muscle using 
Nile tilapia (Oreochromis niloticus) as our model organism. Finally, we 
investigated the link between 5hmC and gene expression in skeletal 
muscle, since it constitutes the majority of the body mass and is directly 
related to growth. 
2. Results 
2.1. Tissue-specific 5hmC levels across the somatotropic axis 
Pituitary, liver and muscle samples were collected from five Nile 
tilapia male siblings that were reared for 8 months in common garden. 
Among the three main tissues that comprise the somatotropic axis, 
5hmC levels were highest in liver, followed by muscle and pituitary. The 
overall 5hmC levels of each tissue followed the sequencing depth of the 
corresponding reduced representation 5hmC profiling (RRHP) libraries 
(see Methods). Pituitary libraries had an average depth of 21.7 M raw 
reads compared to 28.1 M and 22.6 M raw reads in liver and muscle 
libraries, respectively. After quality control, adapter trimming and 
alignment of the sequenced reads to the Nile tilapia genome, an average 
of 10.6, 14.9, and 11.5 M reads were obtained from the libraries pre-
pared from pituitary, liver and muscle, respectively (Fig. S1). 
The Nile tilapia genome contains 1,613,446 CCGG sites in both 
strands across its 22 linkage groups and the mitochondrial genome. 
RRHP captured 75% (1,211,876 CCGG) of all possible sites. The reduced 
coverage was mostly attributed to the size selection during library 
preparation. Compared to the total number of genomic CCGGs, 15.7% 
was significantly hydroxymethylated based on the median filtering of 
5hmC counts (see Methods). The remaining 59.3% was dominated by 
5hmC sites with very low counts across all tissues. A total of 16,812 
5hmCs, which was approximately 1% of the total genomic CCGGs, were 
identified as differentially hydroxymethylated among the three tissues 
(Fig. 1A). 
The highest difference was detected between the muscle and liver 
(MvL), with 15,757 cytosines being differentially hydroxymethylated, 
out of which 3119 were hyper-hydroxymethylated in muscle (q < 0.01). 
By comparing the hydroxymethylation profiles between muscle- 
pituitary (MvP) and liver-pituitary (LvP) we identified 1728 (q <
0.05) and 1467 (q < 0.01) additional DhmCs, respectively (Fig. 1B). An 
overlap of almost 2000 DhmCs was observed between pairs (MvL-LvP, 
MvL-MvP and LvP-MvP); however, we identified only four cytosines 
with significantly different hydroxymethylation levels among all pair-
wise comparisons (Table S1). Two of these four DhmCs were found 
within predicted long non-coding RNAs (LOC102076435 and 
LOC112847764), one DhmC located within the predicted gene gap 
junction delta-3 protein-like (LOC100690349) and one DhmC within the 
par-3 family cell polarity regulator alpha, b (pard3ab). 
2.2. Tissue-specific DNA hydroxymethylation abundance within genomic 
features 
Although DNA hydroxymethylation levels were not significantly 
different among tissues due to high variation among individuals, we 
identified significant differences in DhmC enrichment within the an-
notated features of the Nile tilapia genome. Compared to liver, the 
muscle was characterized by an overall hypo-hydroxymethylation 
across all the annotated features (p < 0.001), including promoter re-
gions (p < 0.05; Fig. 2A). Striking differences were also observed be-
tween pituitary and muscle, with exons and intergenic regions being 
mostly hypo-hydroxymethylated in muscle (p < 0.001; Fig. 2B). By 
comparing liver to pituitary, we observed that the liver genome was 
hyper-hydroxymethylated across all the annotated features with signif-
icant enrichment within introns and exons (p < 0.001) and transcription 
termination sites (p < 0.05; Fig. 2C). The relative enrichment of DhmCs 
was calculated based on the number of 5hmCs with the highest 5hmC 
levels in each annotated feature per tissue. Compared to liver and pi-
tuitary, DhmCs with the highest levels of hydroxymethylation in muscle 
were relatively enriched in introns (12%) and promoters (104%), 
whereas exons were depleted by 58%. 
In contrast, DhmCs with highest levels of hydroxymethylation in 
liver were relatively depleted within promoters and enriched within 
exons, compared to muscle and pituitary (Fig. S2). The highest per-
centage of DhmCs among all tissues was detected within introns (40% on 
average), while DhmCs in intragenic regions including promoters rep-
resented 70%, 74.6% and 71.8% of the entire dataset in muscle, liver, 
and pituitary, respectively. 
2.3. Differentially hydroxymethylated cytosines are found in genes with 
distinct molecular functions in each tissue 
To better understand whether DhmCs were linked to tissue-specific 
genes and potentially their functions, we performed a gene ontology 
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enrichment analysis based on the genes containing or being closely 
associated to DhmCs. In total, we identified 2102 hyper- 
hydroxymethylated genes in muscle compared to liver and pituitary, 
4993 genes in liver compared to muscle and pituitary and 1006 genes in 
the pituitary compared to muscle and liver. Interestingly, we identified 
773 genes containing hyper-hydroxymethylcytosines in both the muscle 
and liver, 40 common genes between muscle and pituitary and 23 genes 
shared between liver and pituitary (Fig. 1C). 
In muscle compared to liver, genes containing hypo-5hmCs (lower 
5hmC levels in muscle) were associated with molecular functions related 
to transcription regulator and GTPase activator activity, GTPase binding 
and Ras GTPase binding. Gene ontologies related to development as well 
as anatomical structure and system development were among the most 
enriched biological processes. Furthermore, we identified 12 biological 
processes linked to metabolism, including regulation of primary, 
cellular, macromolecule, RNA and nitrogen compound metabolic pro-
cess. Interestingly, hypo-5hmCs were assigned to gene ontologies such 
as skeletal system, muscle structure and cartilage development 
(Table S2). On the other hand, hyper-5hmCs (higher 5hmC levels in the 
muscle) were primarily associated to ionotropic glutamate receptor ac-
tivity, signaling receptor activity and cell surface receptor signaling 
pathway, as well as system development and developmental process 
(Table S3). Notably, 773 genes were identified containing both hyper- 
and hypo-5hmCs that occurred in different intragenic loci. These genes 
were primarily linked to the regulation of biological and cellular 
processes, as well as the signal transduction and response to stimulus 
(Table S4). 
In muscle compared to pituitary, hyper-hydroxymethylated genes 
(higher 5hmC levels in the muscle) were associated with tissue 
morphogenesis and the morphogenesis of an epithelium, as well as the 
developmental process and signaling among other gene ontologies 
(Table S5). Hypo-hydroxymethylated genes (lower 5hmC levels in 
muscle) were enriched for functions related to transcription regulator 
activity and the regulation of metabolic and biosynthetic process of 
macromolecules and RNA (Table S6). We identified 40 shared genes 
between muscle and pituitary containing hyper- and hypo-5hmCs in 
different loci. However, due to the relatively low number of genes we 
did not identify any significant enrichment for molecular functions or 
biological processes. 
Compared to pituitary, the liver contained hypo-hydroxymethylated 
genes (lower 5hmC levels in liver) that were enriched for a cell surface 
receptor signaling pathway and axon target recognition (Table S7). In 
contrast, hyper-hydroxymethylated genes (higher 5hmC levels in the 
liver) were enriched for molecular functions related to protein and DNA 
binding. The most enriched biological processes were the regulation of 
cellular and biological processes, signaling and signal transduction 
(Table S8). In total, 23 genes containing hyper- and hypo-5hmCs were 
found within the LvP pairwise comparison. Among them, we identified 
the gene coding for arginine-glutamic acid dipeptide repeats protein 
(rere), which is involved in cell survival and apoptosis [39], and the 
Fig. 1. Venn diagrams representing the RRHP dataset. A) Stacked Venn diagram showing the distribution of total CCGG sites captured by RRHP, substantially 
hydroxymethylated and differentially hydroxymethylated among tissues compare to the total genomic CCGG sites of the Nile tilapia genome. B) Venn diagram 
depicting total differentially hydroxymethylated sites between and among tissue comparisons (MvL - Muscle vs Liver, MvP – Muscle vs Pituitary, and LvP – Liver vs 
Pituitary). C) Venn diagram showing the total and shared number of hyper-hydroxymethylated genes among tissues. Genes containing or associated with a DhmC in 
close proximity based on their distance to TSS were considered differentially hydroxymethylated. 
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protein phosphatase 1 regulatory subunit 3C (ppp1r3c) involved in 
glycogen metabolism as well as the metabolic process of macromole-
cules [40]. 
2.4. Differentially hydroxymethylated genes involved in somatic growth 
Genes that play a critical role in development and somatic growth 
were identified across all pairwise comparisons. Most genes involved in 
somatic growth were hypo-hydroxymethylated in muscle compared to 
liver. These included several fibroblast growth factors (fgf5, fgf6, fgf8, 
fgf12, fgf14 and fgf22), the receptor fgfr3 and the fibroblast growth factor 
receptor substrate 2 (frs2). Only fgf10 and fgfr4 were hyper- 
hydroxymethylated in muscle. Additionally, growth arrest-specific 
proteins (gas2l3 and gas7) and growth differentiation factors (gdf3, 
gdf5, gdf6¸ gdf6a and gdf10) were also hypo-hydroxymethylated in 
muscle. Hypo-5hmCs were detected within the last exon of growth 
hormone secretagogue receptor type 1 (ghsr), the second intron of 
insulin-like growth factor 2 mRNA binding protein 2 (igf2bp2), the first 
and third introns of insulin-like growth factor binding protein 5 (igfbp5) 
and the 32nd intron of IGF like family receptor 1 (igflr1). On the other 
hand, the promoter of the growth hormone releasing hormone (ghrh), 
the first intron of the insulin-like growth factor binding protein 2-B and 
the 29th exon of igflr1 contained a single hyper-5hmC. Several genes 
involved in somatic growth contained both hyper- and hypo-5hmCs in 
different intragenic loci. These included the myoD family inhibitor 
domain-containing protein (mdfic), the multiple epidermal growth 
factor-like domains protein 10 (megf10) and the myosin heavy chain fast 
skeletal muscle (myh) (Fig. 3A; Table S9A). In muscle compared to pi-
tuitary, we identified two hyper-5hmCs located 7549 and 7367 bp, from 
the transcription start site (TSS) of the myostatin (mstn) gene, and a 
single hyper-5hmC at 6945 bp from the TSS of the growth arrest and 
DNA damage inducible gamma (gadd45g) gene. Similar to the compar-
ison between muscle and liver, fibroblast growth factor genes fgf5, fgf12 
and frs2 were hypo-hydroxymethylated in muscle compared to pituitary; 
however, hyper-5hmCs were detected within the fgfr2 and fgfbp3 genes. 
Additionally, two hyper-5hmCs were identified within the 5th exon and 
7th intron of the gene coding for myoD family inhibitor domain- 
containing protein 2 (mdfic2) (Fig. 3B; Table S9B). Several of the 
above-mentioned genes were also differentially hydroxymethylated in 
liver compared to pituitary (Fig. 3C; Table S9C). 
2.5. Gene expression profiling in Nile tilapia fast muscle 
We investigated the correlation between 5hmC levels and gene 
expression in muscle, since it constitutes the majority of the total body 
mass in Nile tilapia and it closely reflects growth rate. The average 
sequencing depth of the RNA-Seq libraries was 26 M reads (Table S10). 
Approximately 1 M reads were excluded from the analysis after quality 
control (Q > 20) and trimming. On average, 2.8 M reads were mapped 
multiple times and 19.2 M reads were mapped uniquely to the reference 
Nile tilapia genome. In total, we identified 80,417 transcripts that were 
ranked based on their normalized counts. The gene with the highest 
expression in Nile tilapia fast muscle was the actin alpha skeletal muscle 
A (LOC100534413), which is involved in several biological processes 
including muscle contraction, myosin binding, skeletal muscle fibre 
development and thin filament assembly. Among the genes with the 
highest expression, we identified several fast skeletal muscle myosin 
light and heavy chains (mylpf, LOC100712344, LOC100707599, 
LOC100698429), creatine kinases muscle a and b (ckma and ckmb), 
ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 1 like 
(atp2a1l) and several isoforms of troponin T (LOC100707421) and 
tropomyosin 1 (tpm1) (Table S11). 
Fig. 2. Histograms depicting the number of differentially hydroxymethylated 
cytosines (DhmCs) per pairwise comparison and annotated feature. Pairwise 
tissue comparisons are presented as (A) for muscle versus liver, (B) muscle 
versus pituitary, and (C) liver versus pituitary. The number of hyper- and hypo- 
hydroxymethylated sites are shown separately for promoters, introns, exons, 
transcription termination sites (TTS) and intergenic regions. P-values were 
calculated using Fisher’s test with 95% confidence interval and asterisks depict 
the p-value [* - (0.01 < p < 0.05); *** - (p < 0.001)]. 
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2.6. Association of muscle-specific gene expression and DNA 
hydroxymethylation 
To investigate the links between DNA hydroxymethylation and gene 
expression levels in muscle, we performed a principal component 
analysis using three variables: the 5hmC levels, the distance to the 
transcription start site (TSS) and gene expression. The first principal 
component (PC1) was strongly related to variation in both the distance 
to TSS (ρ = 0.63) and gene expression (GE; ρ = 0.70), indicating that 
these variables were strongly positively correlated in our data. On the 
other hand, 5hmC levels were strongly represented in the second prin-
cipal component (PC2; ρ = 0.84) revealing no correlation with GE (ρ =
0.10; Fig. 4). Since the first kilobases up- and downstream of promoter 
regions have been previously correlated with gene transcription and 
alternative splicing [41–43], we also investigated the correlation be-
tween gene expression and 5hmC levels in promoters, first introns and 
first exons. 
Consistent with our findings above, we identified a negative corre-
lation between 5hmC levels and gene expression in all three compari-
sons (Fig. 5). Among the most expressed genes in fast muscle, we 
identified 4 differentially hydroxymethylated genes between muscle and 
liver. Two DhmCs were located 19,650 and 19,551 bp upstream of the 
myosin heavy chain fast skeletal muscle (LOC100706261) promoter, 
two DhmCs were located 10,176 and 10,040 bp upstream of the 
nucleoside diphosphate kinase B (LOC100697135) promoter, two 
DhmCs were found within the 16th exon of atp2a1l, one DhmC within 
the 5th exon of myosin light chain 3 skeletal muscle isoform 
(LOC100698429) and one DhmC within the 1st intron of troponin T fast 
Fig. 3. Heatmaps of growth-related genes containing differentially hydroxymethylated cytosines (DhmCs) among the three tissues. The level of 5hmC enrichment is 
mapped based on 5hmC counts across samples. The three heatmaps represent the comparisons between (A) muscle and liver, (B) muscle and pituitary, and (C) liver 
and pituitary. The 5hmC enrichment is represented as a gradient from light blue (low) to red (high). (For interpretation of the references to colour in this figure 
legend, the reader is referred to the web version of this article.) 
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skeletal muscle isoforms (LOC100707421). Surprisingly, all 5hmCs were 
hypo-hydroxymethylated in muscle compared to liver, except the one 
that was located closest to the TSS (1318 bp) and within the 1st intron of 
troponin T fast skeletal muscle isoform (Table 1). 
3. Discussion 
This study presents the first DNA hydroxymethylation profiling of 
the somatotropic axis at single nucleotide resolution in a teleost species. 
We compared the 5hmC levels among tissues and identified the liver as 
the tissue with the highest, the muscle with intermediate and the pitu-
itary with the lowest 5hmC levels (Fig. 6). In contrast to these results, 
global 5hmC levels of the muscle and liver measured by liquid chro-
matography mass spectrometry (LC/MS) in male zebrafish (Danio rerio) 
revealed that muscle had higher 5hmC levels than liver [44]. Similarly, 
5hmC quantification by LC/MS in muscle and liver of mice, showed 
higher 5hmC levels in muscle than liver [45]. These results can poten-
tially be explained either by species-specific 5hmC patterns or by the 
methods used, i.e. reduced representation of the genome using RRHP, 
compared to global 5hmC quantification using LC/MS. The low 5hmC 
content in pituitary gland in Nile tilapia is in accordance with previous 
findings in mice [45]. Indeed, reports have demonstrated that high 
5hmC levels in brain are associated with tissue-specific neuronal func-
tions [46,47], compared to pituitary, which is responsible for hormone 
secretion. 
Based on the functional enrichment analysis of hyper- 
hydroxymethylated genes in muscle compared to liver, we identified 
several genes involved in ionotropic and metabotropic glutamate re-
ceptor activity. These genes were associated with all three types of 
ionotropic glutamate receptors, namely, the N-methyl-D-aspartate 
(NMDA), the kainate and the a-amino-3-hydroxy-5-methyl-4-iso-
xazolepropionic acid receptors while their functions were mostly asso-
ciated with fast synaptic transmission and the modulation of synaptic 
responses [48]. A previous study using C2C12 mouse skeletal myoblasts 
has shown that NMDA receptors play a major role in calcium influx and 
myoblast fusion, which are fundamental processes for muscle growth 
[49]. Furthermore, we also identified several differentially hydrox-
ymethylated metabotropic glutamate receptors (grm1, grm2, grm4, grm7 
and grm8) between muscle and liver, which play critical roles in cell 
survival, metabolism and proliferation through their association with 
the PI3 kinase and the initiation of the PI3K-Akt-mTOR signaling 
pathway [50]. Glutamate receptors were found to be under positive 
selection across several domesticates [51], including fish [52]. Partic-
ularly in sea bass (Dicentrarchus labrax), the identification of genetic 
mutations after many generations in captivity was found to be over-
lapping with early changes in DNA methylation profiles during domes-
tication, suggesting that epimutations potentially drive genome 
Fig. 4. Principal component analysis using three variables. The three variables 
are the 5hmC level, gene expression (GE) corresponding to each 5hmC and their 
distance to the closest transcription start site, across the first two dimensions 
that explain 67.5% of the total dataset variation. Colour coding depicts the 
quality (cos2) of representation for the three variables, with lower, intermediate 
and higher quality represented in blue, yellow and orange, respectively. (For 
interpretation of the references to colour in this figure legend, the reader is 
referred to the web version of this article.) 
Fig. 5. Line graph depicting the correlation between highly and lowly hydroxymethylated genes with their expression. Genes were categorized to highly (red) and 
lowly (light blue) hydroxymethylated based on the mean 5hmC counts across all muscle samples. The total number of genes containing DhmCs is depicted on the y- 
axis in four density quantiles from 0 to 100%, while the x-axis shows mean gene expression. The three graphs from left to right represent the correlations between 
gene expression and 5hmC levels within first exons (A), first introns (B) and promoters (C). P-values were calculated based on two-sample, two-sided Kolmogorov- 
Smirnov test. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.) 
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evolution [53]. Here, we identified significantly hydroxymethylated 
ionotropic and metabotropic glutamate receptors within the somato-
tropic axis, which supports the functional importance of these genes in 
somatic growth. 
Finally, we identified several DhmCs within the receptor-type tyro-
sine-protein phosphatase N2 (ptprn2) gene, which is expressed in ner-
vous and endocrine cells and it is associated with lipid metabolism and 
insulin secretion [54,55]. Previous studies have shown that ptprn2 is 
largely associated with somatic growth, and regulated by epigenetic 
modifications in various biological processes including hepatocellular 
carcinomas [56], breast cancer [57], as well as prenatal growth patterns 
and birthweight in humans [58]. Therefore, it is likely that DNA 
hydroxymethylation may modulate somatic growth indirectly, through 
the regulation of genes related to neuromuscular and neurohepatic 
signals. 
Growth hormone release depends on three hypothalamic factors, 
Table 1 
List of DhmCs between muscle and liver, found within the most expressed genes in muscle. Positive and negative logFC values correspond to hyper- and hypo- 
hydroxymethylation in muscle compared to liver, respectively.  
Chromosome Position LogFC Annotation Dist. to TSS Gene Symbol Description 
NC_031972.2 3,582,578 0.70 Intron (1/11) 1318 LOC100707421 troponin T fast skeletal muscle isoforms 
NC_031973.2 16,443,052 − 1.51 Exon (16/24) 7879 LOC100706607 sarcoplasmic/endoplasmic reticulum calcium ATPase 1 
NC_031986.2 22,143,050 − 1.53 Exon (5/6) 2333 LOC100698429 myosin light chain 3 skeletal muscle isoform 
NC_031969.2 34,504,991 − 1.74 Intergenic 10,176 LOC100697135 nucleoside diphosphate kinase B 
NC_031969.2 34,505,127 − 1.94 Intergenic 10,040 LOC100697135 nucleoside diphosphate kinase B 
NC_031973.2 16,442,970 − 2.01 Exon (16/24) 7797 LOC100706607 sarcoplasmic/endoplasmic reticulum calcium ATPase 1 
NC_031969.2 23,538,241 − 2.72 Intergenic 19,650 LOC100698429 myosin heavy chain fast skeletal muscle 
NC_031969.2 23,538,340 − 3.18 Intergenic 19,551 LOC100698429 myosin heavy chain fast skeletal muscle  
Fig. 6. Graphical summary of the main findings of the study. DNA hydroxymethylation was enriched within gene bodies and promoters (80%) compared to 
intergenic regions (20%). Tissues of the somatotropic axis were differentially hydroxymethylated. The liver had the highest, muscle intermediate, and pituitary the 
lowest 5hmC levels. Several genes involved in somatic growth were found to be differentially hydroxymethylated among all three comparisons (pituitary – muscle, 
muscle – liver and liver – pituitary). 
I. Konstantinidis et al.                                                                                                                                                                                                                          
Genomics 113 (2021) 2953–2964
2960
namely, growth hormone releasing hormone (GHRH), somatostatin 
(SST) and ghrelin multifaceted hormone (GHRL) [59,60]. The latter is 
stimulated by receptors, such as the growth hormone secretagogue re-
ceptor (ghsr), which was found to be hyper-hydroxymethylated in the 
liver, compared to the muscle and pituitary. Ghsr encodes for a tissue- 
specific hormone receptor that is commonly found across the somato-
tropic axis and regulates energy homeostasis, fat distribution and the 
expression of genes involved in lipid metabolism and total body weight 
[61,62]. Notably, among the differentially hydroxymethylated genes, 
we also identified a hyper-5hmC (higher 5hmC level in muscle than 
liver) within the promoter of the growth hormone ghrh as well as several 
hyper-5hmCs (higher 5hmC levels in muscle and pituitary than liver) 
within predicted genes coding for somatostatin in Nile tilapia 
(loc102077970 – somatostatin-1; loc100698045 – somatostatin-1B; 
loc100694069 – somatostatin-2), known also as growth hormone- 
inhibiting hormone. Additionally, we identified differentially hydrox-
ymethylated genes that play critical roles in growth hormone signaling 
and are downstream regulators of somatic growth, such as the insulin- 
like growth factor binding proteins igfbp2, igf2bp2 and igfbp5 and the 
receptor igflr1. In particular, hyper-5hmCs (higher 5hmC levels in 
muscle than liver) were located within igfbp2 and the 29th exon of igflr1 
while hypo-5hmCs (lower 5hmC levels in muscle than liver) were 
located within igfbp5, igf2bp2 and the 32nd intron igflr1 (Table S9A). 
The same genes were also differentially hydroxymethylated between 
liver and pituitary. A hyper-5hmC (higher 5hmC levels in liver than 
pituitary) was found within igf2bp2, and a hypo-5hmC (lower 5hmC 
levels in liver than pituitary) was located within igflr1. Considering that 
epigenetic modifications drive tissue-specific gene expression, it is likely 
that differentially hydroxymethylated cytosines can contribute towards 
the expression of insulin-like growth factor receptor and binding protein 
genes. These results suggest a link between DNA hydroxymethylation 
and the function of the somatotropic axis (Fig. 6). 
Interestingly, several genes were both hyper- and hypo- 
hydroxymethylated between tissues due to the localization of unique 
DhmCs across their gene body or their proximal regions. For example, 
the above-mentioned ptprn2 gene was highly hydroxymethylated in liver 
(compared to muscle) across the 1st, 3rd and 8th introns as well as the 
5th exon, but a hypo-hydroxymethylated cytosine (low 5hmC levels in 
liver compared to muscle) was also present in the 10th intron. Similar 
patterns were observed in other genes, including the multiple epidermal 
growth factor-like domains protein 10 (mefg10) and insulin receptor 
(insr), methyltransferases such as mettl21c and mettl4, adhesion G 
protein-coupled receptors (adgrf4, adgrl2, adgrl3, adgrb1) and several 
transcription factors (atf2, atf3, ebf3, grhl1, gtf3c1, gtf3c3, hsf2, sox4 and 
runx2). Taking into consideration the enrichment of 5hmCs within in-
trons and their positional dynamics between tissues, these findings 
could potentially explain tissue-specific gene expression through the 
regulation of alternative promoters or splicing junctions. Indeed, recent 
studies have shown that DNA hydroxymethylation is involved in alter-
native splicing [63,64] and that positional dynamics of 5hmCs within or 
in proximal distance of genes result in expression changes [35]. 
Additionally, studies in mammals and mammalian cells have shown 
that DNA hydroxymethylation is positively correlated to gene expres-
sion and is present in gene bodies of actively transcribed genes [65–67]. 
Here, even though the correlations of gene expression in the muscle and 
5hmC levels were generally moderate (ρ = 0.47–0.63), we found that 
5hmCs display a positive correlation with distance from TSSs; the farther 
the 5hmCs from a TSS, the higher the expression of genes. Although, this 
correlation included both upstream and downstream 5hmCs from the 
TSS, 80% of those 5hmCs were located within gene bodies. Therefore, 
this correlation was primarily affected by 5hmCs within the downstream 
region of TSSs. Frequently, first introns and exons are positively asso-
ciated with gene regulation [41–43]. By comparing muscle gene 
expression and 5hmC levels of promoters, first introns and first exons, 
we determined that 5hmCs in close proximity to TSSs had an overall 
negative correlation with gene transcription. However, a close 
examination of the top 30 most expressed genes in muscle and their 
hydroxymethylation status revealed that the only hyper-5hmC in muscle 
compared to liver was also the closest one to the TSS of troponin T fast 
skeletal muscle isoform. Several hypo-5hmCs (lower 5hmC levels in 
muscle than liver) were found at a distance of 10–19 kbp upstream from 
the promoter as well as within the open reading frames of highly 
expressed genes in the muscle but none of them were located within the 
first intron or exon. These findings suggest that the position of 5hmCs 
within gene features plays indeed a crucial role in gene repression or 
activation. The overall negative correlation between 5hmCs and gene 
expression in our study is likely attributed to the presence of other 
epigenetic mechanisms that were not profiled here, such as cytosine 
methylation, histone modifications and non-coding RNAs. Although, 
high 5hmC levels are usually correlated with gene activation, there is 
also evidence of 5hmCs being involved in the repression of genes such as 
the insulin-degrading enzyme (IDE) in depressed individuals [68] and 
polycomb groups of developmental regulators [66]. In human, there is a 
high overlap (85.6%) between 5mCs and 5hmCs [69]. Previously, high 
5mC levels within the first intron of genes have been strongly associated 
to low levels of expression across multiple species and tissues [43]. 
Considering the potential overlap between these two cytosine modifi-
cations, their overall contrasting roles in gene regulation, their relative 
abundance (5mCs are estimated to be 14-fold more abundant than 
5hmCs in mammalian embryonic stem cells [28]), and the moderate 
negative correlation between substantially hydroxymethylated genes 
and their expression, we propose that the presence of 5hmCs throughout 
the genome plays a balancing role in gene regulation. 
4. Conclusions 
Somatic growth and normal development are regulated by a complex 
molecular cascade that is affected by several mechanisms, including 
epigenetic modifications. Here, we show that DNA hydroxymethylation 
is present throughout the genome, is characterized by tissue-specific 
profiles and is highly enriched within gene bodies (Fig. 6). 
Several genes that are both directly or indirectly associated with 
functions such as growth hormone release, insulin-like growth factor 
binding, liver metabolism and somatic growth were found to be differ-
entially hydroxymethylated between pituitary, liver and muscle. We 
identified a moderate but significant negative correlation between gene 
expression and 5hmC levels in muscle. However, one of the most 
expressed genes in the muscle (troponin T fast skeletal muscle) contained a 
single hyper-5hmC (higher 5hmC levels in the muscle than liver) within 
the first intron, revealing a positive correlation between DNA hydrox-
ymethylation and gene expression. The high overlap between 5hmCs 
and 5mCs and their overall contrasting roles in gene transcription pin-
points towards a dynamic interrelationship with DNA hydrox-
ymethylation acting as a balancing factor in gene regulation within 
tissues. The identification of tissue-specific epigenetic modifications 
within the somatotropic axis adds an additional layer of complexity to 
our current knowledge about the regulation of growth. 
5. Materials and methods 
5.1. Experimental design and sampling 
Female wild Nile tilapia mouthbrooding fertilized eggs were 
captured using traditional fishing nets and traps at the river Nile in 
Luxor, Egypt. At 9 days post-hatching, the larvae were transported to our 
research facilities in Bodø, Norway. A total of 14 batches of juveniles 
originating from 14 different wild females were tagged and used as the 
base population (F0) for our Nile tilapia breeding program. These Nile 
tilapia were reared in a recirculating aquaculture system (pH = 7.6, 
oxygen saturation = 100%, temperature = 28 ◦C and photoperiod 
adjusted at 11:13 dark:light) and fed ad libitum with 0.15–0.8 mm 
Amber Neptun pellets (Skretting, Norway) as previously described [70]. 
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After a successful reproduction cycle in captivity, we obtained the F1 
generation. These fish were PIT-tagged and reared for 8 months in 
common garden to minimize the effect of environmental factors. For the 
samples used in this study, 5 full-sib F1 males were randomly selected 
from the tank. We focused on Nile tilapia males because they are 
preferred for fish farming, since they grow faster and larger than fe-
males. The fish were euthanized by immersion for 3 min in 10 L of water 
containing 15 mL clove oil pre-mix, consisting of pure clove oil (Sigma 
Aldrich, USA) and 96% ethanol at a 1:9 ratio. Fast (white) muscle, liver 
and pituitary gland were carefully dissected, snap-frozen in liquid ni-
trogen and stored at − 80 ◦C. In particular, fast muscle was extracted 
from a 4 mm cross-section at 0.7 standard length. The samples were 
taken above the lateral line from the left upper white muscle mass. Liver 
samples were collected from the left lobe and around the entry point of 
the portal vein. The pituitary gland was extracted by cutting open the 
skull, removing the brain from the dorsal side and picking the pituitary 
out with forceps. Information regarding the measurements (weight, total 
and standard length) of the fish can be found in Table 2. 
5.2. DNA extraction and RRHP library preparation 
DNA extraction was carried out using the Quick-DNA miniprep plus 
kit (Zymo Research, USA) according to the manufacturer’s instructions. 
Quantification and integrity control of the extracted DNA was per-
formed using Qubit 3.0 fluorometer and the double-stranded DNA high 
sensitivity assay kit (ThermoFisher Scientific, USA) and Tapestation 
2200 (Agilent Technologies, USA), respectively. 
Reduced representation of 5-hydroxymethylcytosine profiling 
(RRHP) was performed according to manufacturer’s protocol (Zymo 
Research). The preparation of RRHP libraries was performed synchro-
nously for all tissues and replicates. The starting DNA concentration was 
150 ng diluted in 10 μL DNAse and RNAse free water. Sequencing was 
performed using Nord University’s inhouse NextSeq500 (Illumina, USA) 
and all libraries were pooled with equal volumes. Finally, they were 
distributed among three High-Output kit v2.5 150 cycle flow cells, 
yielding approximately 360 million single-end reads. 
5.3. RRHP bioinformatic pipeline 
Raw reads were trimmed for adapters using trim_galore v0.4.4 and 
quality check was performed using MultiQC. The software Bowtie 
v0.12.8 was used for the alignment of high quality and trimmed reads to 
the latest Nile tilapia reference genome (NCBI assembly 
GCA_001858045.3) [71] with the following parameters: -S -v 1 -n 1 -m 3 
–strata –best. The chromosome, position and strand information from 
reads that start with CCGG were extracted in text files for each sample. 
These files were used as input into R, where a count matrix was created 
by summing up overlapping chromosomal positions. To minimize the 
false discovery of 5hmCs the data set was filtered twice, as reported 
[70]. Briefly, the first filter removed reads for which more than two 
groups of samples (2 out of 3 tissues) had less than 1 count. For the 
second filter, the median of the entire dataset was calculated and 5hmC 
sites were removed when at least one tissue among the three (5 or more 
samples) had counts equal or less than the median (21 counts). For the 
comparison of 5hmC levels at single nucleotide resolution between the 
three tissues, we used the R package limma [72] and the adjusted p- 
values were calculated using the Benjamini-Hochberg correction. Three 
contrasts were performed comparing the 5hmC levels of i) the muscle 
against the liver (MvL), ii) the muscle against the pituitary gland (MvP) 
and iii) the liver against the pituitary gland (LvP). 
5.4. Functional enrichment analysis 
Differentially hydroxymethylated cytosines (DhmCs) were assigned 
to genes based on their proximal distance to transcription start sites, 
using the all-in-one Perl script annotatepeaks.pl from HOMER (htt 
p://homer.ucsd.edu). Genes associated with DhmCs were considered 
to be differentially hydroxymethylated. DhmCs located within unchar-
acterized genes were excluded from further analysis, since they lack 
information regarding their function. In total, 4590 DhmCs in MvL, 463 
DhmCs in MvP and 367 DhmCs in LvP comparisons were annotated 
within uncharacterized genes. Functional enrichment analysis was 
performed using gProfiler (version: e99_eg46_p14_f929183) with 
default parameters for Oreochromis niloticus. Multiple testing correction 
was performed using the suggested tailor-made algorithm g:SCS and the 
significance threshold was set at 0.05 [73]. The analysis was separated 
in 6 stages using hyper- and hypo-hydroxymethylated genes per pair-
wise tissue comparison as well as 3 additional stages for genes that were 
both hypo- and hyper-hydroxymethylated in a single tissue per pairwise 
tissue comparison. 
5.5. RNA extraction, library preparation and sequencing 
The same fast muscle samples that were used for the RRHP library 
preparation were homogenised in DNA/RNA Shield (Zymo Research) 
using ZR bashing beads lysis tubes (Zymo Research). Homogenization 
was carried out using a Precellys 24 homogenizer (Bertin Instruments, 
France) with 2 cycles at 5000 rpm and 20 s duration. RNA extraction was 
performed using the Quick-RNA miniprep kit (Zymo Research) 
following the manufacturer’s protocol for samples stored in DNA/RNA 
Shield. The Ribo-Zero Gold rRNA removal kit (Illumina) was used to 
ensure the removal of ribosomal RNA. RNA quality was determined 
using the spectrophotometer NanoDrop ND 1000 (ThermoFisher Sci-
entific), while its concentration and integrity was measured with an 
RNA High-sensitivity screentape on a Tapestation 2200 (Agilent Tech-
nologies). For the library preparation, the NEBNEXT Ultra II Directional 
RNA library prep kit for Illumina (NEB, USA) was used following the 
manufacturer’s instructions and recommendations. Each sample was 
tagged with a unique barcode and the libraries were pooled at equimolar 
concentrations. The pool was sequenced at the Norwegian Sequencing 
Centre on a HiSeq 4000 lane (Illumina) in paired-end 150 bp mode. 
5.6. Bioinformatic analysis of RNA-seq data 
The sequencing data obtained above (section 5.5) were trimmed 
using BBDuk of the BBTools Suite (v. 38.22-0, Joint Genome Institute), 
which decontaminates using Kmers. Adapters were trimmed as per 
default (ktrim = r, k = 23, mink = 11, hdist = 1, tpe, tbo) and quality 
trimmed for both sides of the read with the Phred threshold set to 20, 
while reads less than 23 bp after trimming to Q20 were discarded. An 
index was built with the HISAT2 (v. 2.1.0) program [74] using the Nile 
tilapia reference genome above and trimmed reads were aligned by the 
core function of HISAT2 with RNA strandness set to FR and reported 
alignments tailored for downstream transcript assemblers. Alignments 
were sorted by samtools (v. 1.9) and a summarized report for all samples 
was generated using the MultiQC software [75]. Calculation of count 
numbers for each gene was performed by featureCounts (v 1.6.2) [76] of 
the Subread package [77] using the gff3 genome annotation (NCBI, 
ref_O_niloticus_UMD_NMBU_top_level.gff3). Chimeric fragments were 
excluded, duplicates were ignored, only primary alignments were 
Table 2 
Sampling information. The list includes measurements of weight, total and 
standard length of all the individuals used for the current study (n = 5) as well as 
their family and passive integrated transponder tag information.  
Sample 
ID 






M1 f1c9 439E4 1001 37.1 29.7 
M2 f1c9 440D7 683 33.9 26.8 
M3 f1c9 4296F 1298 37.9 29.1 
M4 f1c9 4485C 915 35.9 28 
M5 f1c9 44BE5 708 34.2 26.4  
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counted and fragments were allowed to match more than one meta- 
feature. Further analysis were performed in R (v. 3.6.1) [78] and Rstu-
dio (1.2.1335) [79]. The DESeq2 package [80] was used for applying a 
regularized log transformation to the data in order to minimize differ-
ences between small counts and normalize according to the library size 
in an unbiased manner by prior information. 
For each cytosine with 5hmC information, the mean of 5hmC counts 
across all five biological replicates was used together with the distance 
of each C from the TSS. Each C corresponded to a single expressed gene, 
the value of which was estimated based on the mean of gene expression 
counts across all five biological replicates. In other words, a value of 
gene expression could be attributed to more than one C. Principal 
component analysis and visualizations were performed with the Facto-
MineR (v. 1.42) and factoextra (v. 1.0.5) packages. 
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